1-7 of 7
Sai Prasad Desikan
Close
Sort by
Journal Articles

Genomic Evolution and Resistance during Pirtobrutinib Therapy in Covalent BTK-Inhibitor (cBTKi) Pre-Treated Chronic Lymphocytic Leukemia Patients: Updated Analysis from the BRUIN Study

Jennifer R. Brown, Sai Prasad Desikan, Bastien Nguyen, Helen Won, Shady I. Tantawy, Samuel McNeely, Narasimha Marella, Kevin Ebata, Jennifer A. Woyach, Krish Patel, Constantine S. Tam, Toby A. Eyre, Chan Y. Cheah, Nirav N. Shah, Paolo Ghia, Wojciech Jurczak, Minna Balbas, Binoj Nair, Paolo Abada, Chunxiao Wang, Ying (Denise) Wang, Lindsey E. Roeker, Varsha Gandhi, William G. Wierda
Journal: Blood
Blood (2023) 142 (Supplement 1): 326.
https://doi.org/10.1182/blood-2023-180143
Published: 2023
Journal Articles

Non-Canonical FLT3 Mutations (FLT3m) in Patients (Pts) with Newly Diagnosed Acute Myeloid Leukemia (AML) - Outcomes and Prognosis after FLT3 Inhibitor (FLT3i) and Venetoclax Based Regimens

Sai Prasad Desikan, Naval Daver, Sanam Loghavi, Tapan M. Kadia, Nicholas Short, Courtney D. DiNardo, Gautam Borthakur, Sherry A. Pierce, Keyur P. Patel, Hussein A Abbas, Abhishek Maiti, Guillermo Garcia-Manero, Farhad Ravandi, Hagop Kantarjian, Musa Yilmaz
Journal: Blood
Blood (2022) 140 (Supplement 1): 11788–11790.
https://doi.org/10.1182/blood-2022-166655
Published: 2022
Journal Articles

Cladribine with Low Dose Cytarabine for Unfit Patients: A Safe and Effective Approach with Low Early Mortality in a Population Ineligible for Clinical Trials

Sai Prasad Desikan, Hagop Kantarjian, Elias Jabbour, Kelly S. Chien, Guillermo Montalban-Bravo, Yesid Alvarado, Gautam Borthakur, Ghayas C. Issa, Naval Daver, Naveen Pemmaraju, Musa Yilmaz, Danielle Hammond, Abhishek Maiti, Courtney D. DiNardo, Farhad Ravandi, Guillermo Garcia-Manero, Tapan M. Kadia
Journal: Blood
Blood (2022) 140 (Supplement 1): 3301–3303.
https://doi.org/10.1182/blood-2022-169824
Published: 2022
Journal Articles

Early Treatment with Ofatumumab in Patients with High-Risk CLL

Sai Prasad Desikan, Michael J. Keating, Alessandra Ferrajoli, Nitin Jain, Maro Ohanian, Naveen Pemmaraju, Courtney D. DiNardo, Marina Konopleva, Tapan M. Kadia, Susan O'Brien, Zeev E. Estrov, Deborah A Thomas, Jan A. Burger, Philip A. Thompson, William G. Wierda
Journal: Blood
Blood (2022) 140 (Supplement 1): 9876–9878.
https://doi.org/10.1182/blood-2022-167284
Published: 2022
Journal Articles

Updated Phase IIb Results of Venetoclax with FLAG-IDA in Relapsed or Refractory Acute Myeloid Leukemia

Sai Prasad Desikan, Marina Konopleva, Koichi Takahashi, Curtis A Lachowiez, Sanam Loghavi, Lian-Chun Xiao, Tapan M. Kadia, Naval Daver, Nicholas Short, Koji Sasaki, Gautam Borthakur, Ghayas C. Issa, Abhishek Maiti, Kelly S. Chien, Yesid Alvarado, Guillermo Montalban-Bravo, Lucia Masarova, Musa Yilmaz, Michael Andreeff, Elias Jabbour, Guillermo Garcia-Manero, Steven M. Kornblau, Farhad Ravandi, Hagop Kantarjian, Courtney D. DiNardo
Journal: Blood
Blood (2022) 140 (Supplement 1): 534–536.
https://doi.org/10.1182/blood-2022-164922
Published: 2022
Journal Articles

A Phase I/II Study of Sapacitabine and Venetoclax in Relapsed/Refractory Acute Myeloid Leukemia

Sai Prasad Desikan, Hagop Kantarjian, Courtney D. DiNardo, Gautam Borthakur, Naval Daver, Naveen Pemmaraju, Yesid Alvarado, Jan A. Burger, Debra Bull Linderman, Sherry A. Pierce, Farhad Ravandi, Guillermo Garcia-Manero, Tapan M. Kadia
Journal: Blood
Blood (2021) 138 (Supplement 1): 3419.
https://doi.org/10.1182/blood-2021-151605
Published: 2021
Journal Articles

A Phase II Study of Azacitidine, Venetoclax and Trametinib in Relapsed/Refractory AML Harboring a Ras Pathway-Activating Mutation

Sai Prasad Desikan, Farhad Ravandi, Naveen Pemmaraju, Marina Konopleva, Sanam Loghavi, Gautam Borthakur, Elias J. Jabbour, Naval Daver, Nitin Jain, Kelly S. Chien, Abhishek Maiti, Guillermo Montalban-Bravo, Tapan M. Kadia, Monica Kwari, Hagop Kantarjian, Nicholas J. Short
Journal: Blood
Blood (2021) 138 (Supplement 1): 4436.
https://doi.org/10.1182/blood-2021-151707
Published: 2021